STOCK TITAN

Concentrix SEC Filings

CNXC NASDAQ

Welcome to our dedicated page for Concentrix SEC filings (Ticker: CNXC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Concentrix Corporation (NASDAQ: CNXC) SEC filings page on Stock Titan provides access to the company’s official disclosures as filed with the U.S. Securities and Exchange Commission. As a Fortune 500 public company, Concentrix uses SEC reports to communicate details about its financial performance, risk factors, capital structure, and significant corporate events.

Among the key filings, investors typically review annual reports on Form 10-K and quarterly reports on Form 10-Q to understand revenue trends, operating income, non-GAAP measures referenced in earnings releases, cash flow, and segment information. Current reports on Form 8-K, such as those furnished for quarterly earnings announcements, give timely updates on results of operations and financial condition, and may include press releases as exhibits.

For those tracking ownership and governance, Forms 3, 4, and 5 (if available) can be used to monitor insider transactions by directors, officers, and significant shareholders. Proxy statements on Schedule 14A, when filed, typically provide information on executive compensation, board structure, and matters submitted to shareholder votes.

On Stock Titan, Concentrix filings are supplemented with AI-powered summaries that explain the main points of lengthy documents in clear language. Real-time updates from the EDGAR system help users see new CNXC filings as they appear, while AI-generated highlights make it easier to identify sections related to non-GAAP metrics, AI and technology investments, and other topics emphasized in the company’s earnings materials. This page is a useful starting point for anyone researching Concentrix’s regulatory history, financial reporting practices, and material disclosures.

Rhea-AI Summary

Groupe Bruxelles Lambert and its affiliates amended their Schedule 13D on Concentrix Corporation to update ownership percentages. They report beneficial ownership of 8,773,667 shares of common stock, representing about 14.24% of Concentrix’s outstanding shares, based on 61,597,304 shares outstanding as of January 16, 2026.

The change in percentage ownership results solely from a decrease in Concentrix’s total shares outstanding. The filing also notes potential receipt of 442,759 additional earnout shares if specified share-price conditions are met and reiterates investor rights, including board nomination, lock-up, and registration rights under an existing Investor Rights Agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported routine equity compensation activity involving company common stock. On January 28, 2026, he acquired 2,855 shares of common stock at $0 per share upon the vesting of restricted stock units granted under the 2020 Stock Incentive Plan and tied to performance metrics over a three-year period ending November 30, 2025.

On the same date, 1,210 shares were withheld at a price of $36.32 per share, a transaction coded as "F," typically reflecting shares surrendered to cover tax obligations. After these transactions, Caldwell directly owned 361,075 shares of Concentrix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corp Chief Financial Officer Valentine Andre S reported stock transactions dated January 28, 2026. The filing shows an acquisition of 436 shares of common stock at $0 per share, tied to restricted stock units that vested under the 2020 Stock Incentive Plan after performance was measured over a three-year period ending November 30, 2025.

The report also shows a disposition of 130 shares of common stock at $36.32 per share on the same date. After these transactions, the executive directly held 87,430 shares of Concentrix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Concentrix Corp EVP Cormac J. Twomey reported routine equity compensation activity. On January 28, 2026, he acquired 491 shares of common stock at $0 upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 231 shares were disposed of at $36.32 per share, reflecting shares withheld to cover taxes. After these transactions, he directly owned 58,434 Concentrix common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corp executive Jane Fogarty reported routine equity compensation activity. On January 28, 2026, she acquired 220 shares of common stock at $0 per share upon vesting of performance-based restricted stock units granted under the 2020 Stock Incentive Plan. On the same date, 79 shares were disposed of at $36.32 per share, typically reflecting shares withheld to cover taxes, leaving her with 31,593 shares of Concentrix common stock held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corp President and CEO Christopher A. Caldwell reported a disposition of company common stock. On January 27, 2026, a transaction coded "F" involved 2,591 shares of Concentrix common stock at a price of $41.61 per share. Following this transaction, Caldwell beneficially owned 359,430 shares of Concentrix common stock in direct ownership.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Concentrix Corp executive Cormac J. Twomey reported a small share disposition under a Form 4 filing. On 01/27/2026, Twomey, EVP, Global Ops & Delivery, recorded a transaction in Common Stock coded "F" involving 495 shares at $41.61 per share. Following this transaction, he directly beneficially owned 58,174 shares of Concentrix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corp’s Chief Financial Officer, Valentine Andre S, reported a small stock disposition. On January 27, 2026, the CFO disposed of 278 shares of common stock at $41.61 per share, coded as transaction type “F.”

After this transaction, the filing shows the CFO directly beneficially owning 87,124 shares of Concentrix common stock. The filing is a routine Form 4 insider ownership update and does not describe any additional transactions or derivative securities activity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Concentrix Corp executive Jane Fogarty, EVP, Legal, reported a small change in her holdings of Concentrix common stock. On January 27, 2026, she disposed of 168 shares of common stock at a price of $41.61 per share. After this transaction, she directly beneficially owns 31,452 shares of Concentrix common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Concentrix Corporation files its annual report describing a large, global customer experience and digital operations business serving more than 2,000 clients, including over 160 Fortune Global 500 brands. The company delivers end-to-end CX, analytics, AI-enabled and agentic AI services across 74 countries and multiple industries.

Concentrix highlights growth via major acquisitions such as Webhelp and SAI Digital, and the launch of its Intelligent Experience (iX) AI product suite. The report also outlines key risks, including macroeconomic pressures, cyberattacks, rapid AI-driven technology change, regulatory complexity, and the need to attract and retain skilled staff worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report

FAQ

How many Concentrix (CNXC) SEC filings are available on StockTitan?

StockTitan tracks 72 SEC filings for Concentrix (CNXC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Concentrix (CNXC)?

The most recent SEC filing for Concentrix (CNXC) was filed on January 30, 2026.